Cue Health to Present at the Goldman Sachs 44th Annual Global Healthcare Conference
May 31 2023 - 4:01PM
Business Wire
Cue Health (“Cue”) (Nasdaq: HLTH), a healthcare technology
company, announced today that its management team will present at
the Goldman Sachs 44th Annual Global Healthcare Conference on
Wednesday, June 14, 2023 at 4:00 p.m. Pacific Time at the Waldorf
Astoria Monarch Beach Resort & Club.
A live audio webcast and replay of the presentation may be
accessed for 180 days on the “Investor Relations” section of the
company’s website at: https://cuehealth.com/.
About Cue Health Cue Health Inc. (Nasdaq: HLTH) is a
healthcare technology company that uses diagnostic-enabled care to
empower people to live their healthiest lives. The Cue Health
platform offers individuals and healthcare providers convenient and
personalized access to lab-quality diagnostic tests at home and at
the point of care, as well as on-demand telehealth consultations
and treatment options for a wide range of health and wellness
needs. Cue’s customers include federal and state public sector
agencies and the private sector, which includes healthcare
providers, enterprises, and individual consumers. Cue’s COVID-19
test was the first FDA-authorized molecular diagnostic test for
at-home and over-the-counter use without a prescription. Cue has
since received Emergency Use Authorization from the FDA for its
molecular mpox test at the point of care and, to expand its test
menu, the company has a number of other submissions under review by
the FDA. Cue, founded in 2010, owns over 100 patents and is
headquartered in San Diego. For more information, please visit
www.cuehealth.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230531005904/en/
Lorna Williams ir@cuehealth.com Cue Health
press@cuehealth.com
Cue Health (NASDAQ:HLTH)
Historical Stock Chart
From May 2024 to Jun 2024
Cue Health (NASDAQ:HLTH)
Historical Stock Chart
From Jun 2023 to Jun 2024